Toll Free : +1-855-465-4651 | (DE) : +49 322 210 92714 | (USA) : +1-386-310-3803 | Contact : sales@qygroup.biz

Search Market Research Reports from Top Publishers

Global Bipolar Disorder Therapeutic Market Report, History and Forecast 2012-2025 By Manufacturers, Breakdown Data, Key Regions and Application

Aug-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 109

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE

Global Bipolar Disorder Therapeutic Market Report, History and Forecast 2012-2025 By Manufacturers, Breakdown Data, Key Regions and Application

Aug-2018 | Published By : QYResearch | Category : Pharmaceuticals | Pages : 109 | Format : PDF

This report studies the global Bipolar Disorder Therapeutic market status and forecast, categorizes the global Bipolar Disorder Therapeutic market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
The Americas accounted for the majority market share during 2016 and will continue to dominate the market during the forecasted period. Some of the major factors responsible for the market's growth in the region are the high incidence of bipolar disorder symptoms in the US, the growing number of pipeline products, the rising awareness about these disorders in the region, and the growing prevalence of pediatric bipolar disorders.
The global Bipolar Disorder Therapeutic market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
    Eli Lilly
    Bristol-Myers Squibb
    AstraZeneca
    Allergan
    Astellas Pharma
    GlaxoSmithKline
    Janssen Pharmaceuticals
    ...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
    North America
    Europe
    China
    Japan
    India
    Southeast Asia
    Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antipsychotics
    Anticonvulsants
    Mood Stabilizers

By Application, the market can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

The study objectives of this report are:
    To analyze and study the global Bipolar Disorder Therapeutic capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
    Focuses on the key Bipolar Disorder Therapeutic manufacturers, to study the capacity, production, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Bipolar Disorder Therapeutic are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Bipolar Disorder Therapeutic Manufacturers
Bipolar Disorder Therapeutic Distributors/Traders/Wholesalers
Bipolar Disorder Therapeutic Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Bipolar Disorder Therapeutic market, by end-use.
Detailed analysis and profiles of additional market players.
<pre>Table of Contents Global Bipolar Disorder Therapeutic Market Professional Survey Report 2018 1 Industry Overview of Bipolar Disorder Therapeutic 1.1 Definition and Specifications of Bipolar Disorder Therapeutic 1.1.1 Definition of Bipolar Disorder Therapeutic 1.1.2 Specifications of Bipolar Disorder Therapeutic 1.2 Classification of Bipolar Disorder Therapeutic 1.2.1 Antipsychotics 1.2.2 Anticonvulsants 1.2.3 Mood Stabilizers 1.3 Applications of Bipolar Disorder Therapeutic 1.3.1 Hospital Pharmacies 1.3.2 Retail Pharmacies 1.3.3 Online Pharmacies 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 Southeast Asia 1.4.6 India 2 Manufacturing Cost Structure Analysis of Bipolar Disorder Therapeutic 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Bipolar Disorder Therapeutic 2.3 Manufacturing Process Analysis of Bipolar Disorder Therapeutic 2.4 Industry Chain Structure of Bipolar Disorder Therapeutic 3 Technical Data and Manufacturing Plants Analysis of Bipolar Disorder Therapeutic 3.1 Capacity and Commercial Production Date of Global Bipolar Disorder Therapeutic Major Manufacturers in 2017 3.2 Manufacturing Plants Distribution of Global Bipolar Disorder Therapeutic Major Manufacturers in 2017 3.3 R&D Status and Technology Source of Global Bipolar Disorder Therapeutic Major Manufacturers in 2017 3.4 Raw Materials Sources Analysis of Global Bipolar Disorder Therapeutic Major Manufacturers in 2017 4 Global Bipolar Disorder Therapeutic Overall Market Overview 4.1 2013-2018E Overall Market Analysis 4.2 Capacity Analysis 4.2.1 2013-2018E Global Bipolar Disorder Therapeutic Capacity and Growth Rate Analysis 4.2.2 2017 Bipolar Disorder Therapeutic Capacity Analysis (Company Segment) 4.3 Sales Analysis 4.3.1 2013-2018E Global Bipolar Disorder Therapeutic Sales and Growth Rate Analysis 4.3.2 2017 Bipolar Disorder Therapeutic Sales Analysis (Company Segment) 4.4 Sales Price Analysis 4.4.1 2013-2018E Global Bipolar Disorder Therapeutic Sales Price 4.4.2 2017 Bipolar Disorder Therapeutic Sales Price Analysis (Company Segment) 5 Bipolar Disorder Therapeutic Regional Market Analysis 5.1 North America Bipolar Disorder Therapeutic Market Analysis 5.1.1 North America Bipolar Disorder Therapeutic Market Overview 5.1.2 North America 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.1.3 North America 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.1.4 North America 2017 Bipolar Disorder Therapeutic Market Share Analysis 5.2 Europe Bipolar Disorder Therapeutic Market Analysis 5.2.1 Europe Bipolar Disorder Therapeutic Market Overview 5.2.2 Europe 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.2.3 Europe 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.2.4 Europe 2017 Bipolar Disorder Therapeutic Market Share Analysis 5.3 China Bipolar Disorder Therapeutic Market Analysis 5.3.1 China Bipolar Disorder Therapeutic Market Overview 5.3.2 China 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.3.3 China 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.3.4 China 2017 Bipolar Disorder Therapeutic Market Share Analysis 5.4 Japan Bipolar Disorder Therapeutic Market Analysis 5.4.1 Japan Bipolar Disorder Therapeutic Market Overview 5.4.2 Japan 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.4.3 Japan 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.4.4 Japan 2017 Bipolar Disorder Therapeutic Market Share Analysis 5.5 Southeast Asia Bipolar Disorder Therapeutic Market Analysis 5.5.1 Southeast Asia Bipolar Disorder Therapeutic Market Overview 5.5.2 Southeast Asia 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.5.3 Southeast Asia 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.5.4 Southeast Asia 2017 Bipolar Disorder Therapeutic Market Share Analysis 5.6 India Bipolar Disorder Therapeutic Market Analysis 5.6.1 India Bipolar Disorder Therapeutic Market Overview 5.6.2 India 2013-2018E Bipolar Disorder Therapeutic Local Supply, Import, Export, Local Consumption Analysis 5.6.3 India 2013-2018E Bipolar Disorder Therapeutic Sales Price Analysis 5.6.4 India 2017 Bipolar Disorder Therapeutic Market Share Analysis 6 Global 2013-2018E Bipolar Disorder Therapeutic Segment Market Analysis (by Type) 6.1 Global 2013-2018E Bipolar Disorder Therapeutic Sales by Type 6.2 Different Types of Bipolar Disorder Therapeutic Product Interview Price Analysis 6.3 Different Types of Bipolar Disorder Therapeutic Product Driving Factors Analysis 6.3.1 Antipsychotics Growth Driving Factor Analysis 6.3.2 Anticonvulsants Growth Driving Factor Analysis 6.3.3 Mood Stabilizers Growth Driving Factor Analysis 7 Global 2013-2018E Bipolar Disorder Therapeutic Segment Market Analysis (by Application) 7.1 Global 2013-2018E Bipolar Disorder Therapeutic Consumption by Application 7.2 Different Application of Bipolar Disorder Therapeutic Product Interview Price Analysis 7.3 Different Application of Bipolar Disorder Therapeutic Product Driving Factors Analysis 7.3.1 Hospital Pharmacies of Bipolar Disorder Therapeutic Growth Driving Factor Analysis 7.3.2 Retail Pharmacies of Bipolar Disorder Therapeutic Growth Driving Factor Analysis 7.3.3 Online Pharmacies of Bipolar Disorder Therapeutic Growth Driving Factor Analysis 8 Major Manufacturers Analysis of Bipolar Disorder Therapeutic 8.1 Eli Lilly 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Eli Lilly 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Eli Lilly 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.2 Bristol-Myers Squibb 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Bristol-Myers Squibb 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Bristol-Myers Squibb 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.3 AstraZeneca 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 AstraZeneca 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 AstraZeneca 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.4 Allergan 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Allergan 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Allergan 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.5 Astellas Pharma 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Astellas Pharma 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Astellas Pharma 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.6 GlaxoSmithKline 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 GlaxoSmithKline 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 GlaxoSmithKline 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 8.7 Janssen Pharmaceuticals 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Janssen Pharmaceuticals 2017 Bipolar Disorder Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Janssen Pharmaceuticals 2017 Bipolar Disorder Therapeutic Business Region Distribution Analysis 9 Development Trend of Analysis of Bipolar Disorder Therapeutic Market 9.1 Global Bipolar Disorder Therapeutic Market Trend Analysis 9.1.1 Global 2018-2025 Bipolar Disorder Therapeutic Market Size (Volume and Value) Forecast 9.1.2 Global 2018-2025 Bipolar Disorder Therapeutic Sales Price Forecast 9.2 Bipolar Disorder Therapeutic Regional Market Trend 9.2.1 North America 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.2.2 Europe 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.2.3 China 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.2.4 Japan 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.2.5 Southeast Asia 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.2.6 India 2018-2025 Bipolar Disorder Therapeutic Consumption Forecast 9.3 Bipolar Disorder Therapeutic Market Trend (Product Type) 9.4 Bipolar Disorder Therapeutic Market Trend (Application) 10 Bipolar Disorder Therapeutic Marketing Type Analysis 10.1 Bipolar Disorder Therapeutic Regional Marketing Type Analysis 10.2 Bipolar Disorder Therapeutic International Trade Type Analysis 10.3 Traders or Distributors with Contact Information of Bipolar Disorder Therapeutic by Region 10.4 Bipolar Disorder Therapeutic Supply Chain Analysis 11 Consumers Analysis of Bipolar Disorder Therapeutic 11.1 Consumer 1 Analysis 11.2 Consumer 2 Analysis 11.3 Consumer 3 Analysis 11.4 Consumer 4 Analysis 12 Conclusion of the Global Bipolar Disorder Therapeutic Market Professional Survey Report 2017 Methodology Analyst Introduction Data Source</pre>


 Latest Research Reports